Novacyt S.A. (NVYTF)
USD 0.54
(0.0%)
USD 0.54
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -29.51 Million GBP | 23.62% |
| 2022 | -23.39 Million GBP | -200.1% |
| 2021 | -7.79 Million GBP | -104.66% |
| 2020 | 167.44 Million GBP | 11135.49% |
| 2019 | -1.51 Million EUR | -21.52% |
| 2018 | -1.24 Million EUR | 65.45% |
| 2017 | -3.61 Million EUR | 4.96% |
| 2016 | -3.8 Million EUR | 60.92% |
| 2015 | -9.73 Million EUR | -556.87% |
| 2014 | -1.48 Million EUR | -37.9% |
| 2013 | -1.07 Million EUR | -129.3% |
| 2012 | -468.46 Thousand EUR | 18.15% |
| 2011 | -572.31 Thousand EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -8.55 Million GBP | 19.02% |
| 2024 Q2 | -8.55 Million GBP | 0.0% |
| 2023 Q4 | -10.56 Million GBP | 8.05% |
| 2023 FY | -17.86 Million GBP | 23.62% |
| 2023 Q1 | -3.27 Million GBP | 59.38% |
| 2023 Q2 | -6.53 Million GBP | -99.49% |
| 2023 Q3 | -11.48 Million GBP | -75.87% |
| 2022 FY | -23.39 Million GBP | -200.1% |
| 2022 Q1 | -4.12 Million GBP | -132.77% |
| 2022 Q2 | -8.54 Million GBP | -107.07% |
| 2022 Q3 | -7.57 Million GBP | 11.36% |
| 2022 Q4 | -8.05 Million GBP | -6.44% |
| 2021 Q4 | 12.58 Million GBP | 77.04% |
| 2021 FY | -7.79 Million GBP | -104.66% |
| 2021 Q1 | 11.4 Million GBP | -82.78% |
| 2021 Q2 | 21.78 Million GBP | 91.02% |
| 2021 Q3 | 7.11 Million GBP | -67.37% |
| 2020 Q1 | 21.11 Million GBP | 3994.23% |
| 2020 Q2 | 44.24 Million GBP | 109.5% |
| 2020 Q3 | 66.22 Million GBP | 49.7% |
| 2020 FY | 167.44 Million GBP | 11135.49% |
| 2020 Q4 | 66.22 Million GBP | 0.0% |
| 2019 FY | -1.51 Million EUR | -21.52% |
| 2019 Q2 | -541.34 Thousand GBP | -110.22% |
| 2019 Q3 | -335.92 Thousand GBP | 37.95% |
| 2019 Q1 | -257.51 Thousand GBP | -130.92% |
| 2019 Q4 | -542.29 Thousand GBP | -61.43% |
| 2018 Q4 | 832.94 Thousand GBP | 1217.06% |
| 2018 Q2 | -250.81 Thousand GBP | -0.77% |
| 2018 Q1 | -248.89 Thousand GBP | -117.78% |
| 2018 FY | -1.24 Million EUR | 65.45% |
| 2018 Q3 | 63.24 Thousand GBP | 125.21% |
| 2017 Q3 | -332.56 Thousand GBP | 33.23% |
| 2017 FY | -3.61 Million EUR | 4.96% |
| 2017 Q4 | 1.39 Million GBP | 520.87% |
| 2017 Q2 | -498.06 Thousand GBP | -2.98% |
| 2017 Q1 | -483.64 Thousand GBP | -25.28% |
| 2016 FY | -3.8 Million EUR | 60.92% |
| 2016 Q4 | -386.05 Thousand GBP | 1.43% |
| 2016 Q1 | -857.54 Thousand GBP | -18.51% |
| 2016 Q2 | -905.94 Thousand GBP | -5.64% |
| 2016 Q3 | -391.65 Thousand GBP | 56.77% |
| 2015 Q1 | -518.47 Thousand GBP | -7.84% |
| 2015 Q3 | -724.6 Thousand GBP | -42.68% |
| 2015 Q4 | -723.57 Thousand GBP | 0.14% |
| 2015 FY | -9.73 Million EUR | -556.87% |
| 2015 Q2 | -507.87 Thousand GBP | 2.04% |
| 2014 Q3 | -481.58 Thousand GBP | -98.57% |
| 2014 Q4 | -480.76 Thousand GBP | 0.17% |
| 2014 FY | -1.48 Million EUR | -37.9% |
| 2014 Q2 | -242.52 Thousand GBP | 3.18% |
| 2014 Q1 | -250.47 Thousand GBP | 12.22% |
| 2013 Q1 | -251.55 Thousand GBP | 0.0% |
| 2013 Q3 | -286.94 Thousand GBP | -12.53% |
| 2013 Q4 | -285.34 Thousand GBP | 0.56% |
| 2013 FY | -1.07 Million EUR | -129.3% |
| 2013 Q2 | -254.98 Thousand GBP | -1.36% |
| 2012 FY | -468.46 Thousand EUR | 18.15% |
| 2011 FY | -572.31 Thousand EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | -703 Thousand USD | -4098.578% |
| SS Innovations International, Inc. | -20.66 Million USD | -42.808% |
| Össur hf. | 87.46 Million USD | 133.748% |
| Össur hf. | 87.46 Million USD | 133.748% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| QHSLab, Inc. | -240.15 Thousand USD | -12190.242% |
| BrainsWay Ltd. | -4.92 Million USD | -499.066% |
| BioElectronics Corporation | -274.29 Thousand USD | -10660.874% |
| AVITA Medical, Inc. | -40.4 Million USD | 26.944% |
| Zecotek Photonics Inc. | -3.65 Million USD | -707.16% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| Wellstar International, Inc. | -1.79 Million USD | -1544.624% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 10717.381% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 1518.357% |
| Escalon Medical Corp. | -104.47 Thousand USD | -28151.464% |
| Aurora Spine Corporation | -446.19 Thousand USD | -6515.03% |
| NewCardio, Inc. | -9.45 Million USD | -212.034% |
| Avitar, Inc. | 2.73 Million USD | 1180.06% |
| Vivos Inc. | -2.79 Million USD | -956.73% |
| Theraclion SA | -3.48 Million USD | -747.942% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | -12241.219% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -1566.025% |
| Positron Corporation | -1.36 Million USD | -2069.098% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -7689.795% |
| Nanomix Corporation | -8.43 Million USD | -249.833% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | -4074.658% |
| Stratec SE | 25.26 Million USD | 216.811% |
| Heart Tronics, Inc. | 14.46 Million USD | 304.121% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -24389.322% |
| Electromedical Technologies, Inc. | -2.06 Million USD | -1329.387% |
| Lombard Medical, Inc. | -29.33 Million USD | -0.617% |
| ALR Technologies Inc. | -2.94 Million USD | -901.793% |
| MicroPort Scientific Corporation | -516.16 Million USD | 94.282% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 73539.327% |
| VMS Rehab Systems, Inc. | -68.66 USD | -42988539.674% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | -42.385% |
| Guided Therapeutics, Inc. | -3.45 Million USD | -753.804% |
| SANUWAVE Health, Inc. | -540 Thousand USD | -5365.926% |
| Ingen Technologies, Inc. | -1.61 Million USD | -1729.153% |
| United American Healthcare Corporation | -67 Thousand USD | -43953.731% |
| Odyssey Group International, Inc. | 14.26 Million USD | 306.969% |
| IR-Med Inc. | -4.91 Million USD | -501.018% |
| Polarean Imaging plc | -12.55 Million USD | -135.072% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | -7143.546% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | -4550.474% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | -4806.894% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 6836.045% |
| Urologix, Inc. | -6.93 Million USD | -325.916% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | -2236.359% |
| Nexeon MedSystems Inc. | -6.26 Million USD | -371.126% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -12719.611% |
| Smith & Nephew plc | 425 Million USD | 106.945% |
| NIOX Group Plc | 4.6 Million USD | 741.652% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 7790.063% |
| Broncus Holding Corporation | -33.22 Million USD | 11.153% |
| Brain Scientific Inc. | -9.6 Million USD | -207.189% |
| Pressure BioSciences, Inc. | -9.5 Million USD | -210.585% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -48526.831% |